Kuros Biosciences AG (SWX:KURN)

Market Cap	1.25B
Revenue (ttm)	103.35M
Net Income (ttm)	-6.07M
Shares Out	39.15M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	108.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	273,267
Average Volume	164,341
Open	31.56
Previous Close	31.60
Day's Range	31.40 - 32.48
52-Week Range	14.00 - 34.20
Beta	0.67
RSI	69.22
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.